ES420386A1 - Un procedimiento para preparar un pentanorprostaglandinas. - Google Patents

Un procedimiento para preparar un pentanorprostaglandinas.

Info

Publication number
ES420386A1
ES420386A1 ES420386A ES420386A ES420386A1 ES 420386 A1 ES420386 A1 ES 420386A1 ES 420386 A ES420386 A ES 420386A ES 420386 A ES420386 A ES 420386A ES 420386 A1 ES420386 A1 ES 420386A1
Authority
ES
Spain
Prior art keywords
carbon atoms
alpha
hydrogen
see formula
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES420386A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES420386A1 publication Critical patent/ES420386A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/30Compounds having groups
    • C07C43/315Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/34Unsaturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
ES420386A 1972-11-08 1973-11-09 Un procedimiento para preparar un pentanorprostaglandinas. Expired ES420386A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
ES420386A1 true ES420386A1 (es) 1976-07-01

Family

ID=23177829

Family Applications (3)

Application Number Title Priority Date Filing Date
ES420386A Expired ES420386A1 (es) 1972-11-08 1973-11-09 Un procedimiento para preparar un pentanorprostaglandinas.
ES444398A Expired ES444398A1 (es) 1972-11-08 1976-01-16 Un procedimiento para preparar compuestos intermedios de o- mega-pentanorprostaglandinas.
ES456279A Expired ES456279A1 (es) 1972-11-08 1977-11-25 Un procedimiento para preparar compuestos de cetofosfonato.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES444398A Expired ES444398A1 (es) 1972-11-08 1976-01-16 Un procedimiento para preparar compuestos intermedios de o- mega-pentanorprostaglandinas.
ES456279A Expired ES456279A1 (es) 1972-11-08 1977-11-25 Un procedimiento para preparar compuestos de cetofosfonato.

Country Status (20)

Country Link
JP (1) JPS5714347B2 (es)
AT (1) AT345999B (es)
BE (1) BE807046A (es)
CA (1) CA1033727A (es)
CH (1) CH593930A5 (es)
DE (1) DE2355731C3 (es)
DK (1) DK143499C (es)
ES (3) ES420386A1 (es)
FI (1) FI58912C (es)
FR (3) FR2205338B1 (es)
GB (1) GB1456838A (es)
IE (1) IE40043B1 (es)
IL (2) IL43571A (es)
IN (1) IN139265B (es)
NL (1) NL7315307A (es)
NO (2) NO143663C (es)
PH (2) PH13261A (es)
SE (4) SE412229B (es)
SU (2) SU667131A3 (es)
ZA (1) ZA738595B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
JPS5823393B2 (ja) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ノ セイゾウホウホウ
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
US4074063A (en) * 1976-02-11 1978-02-14 Miles Laboratories, Inc. Bicycloalkyl derivatives of prostaglandins
NZ183136A (en) * 1976-02-11 1978-11-13 Miles Lab Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
DE2753995A1 (de) * 1977-12-03 1979-06-07 Bayer Ag Neue bicycloalkenyl-prostaglandine und verfahren zu ihrer herstellung
BR9812631A (pt) * 1997-09-09 2000-08-22 Procter & Gamble Tetraidro prostaglandinas substituìdas por c16-c20 aromáticos úteis como agonistas de fp
TR200000670T2 (tr) * 1997-09-09 2000-11-21 The Procter & Gamble Company FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
ID23971A (id) * 1997-09-09 2000-06-14 Procter & Gamble Prostaglandin tetrahidro tersubstitusic c<16>-c<20> aromatik yang berguna sebagai agonis fp
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
ES2326558T3 (es) * 2007-11-28 2009-10-14 Bauer Maschinen Gmbh Torno.
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4864073A (es) * 1971-04-30 1973-09-05

Also Published As

Publication number Publication date
FR2286147A1 (fr) 1976-04-23
IE40043L (en) 1974-05-08
SE7612261L (sv) 1976-11-03
IN139265B (es) 1976-05-29
DE2355731C3 (de) 1981-01-15
FR2205338A1 (es) 1974-05-31
FR2286147B1 (es) 1978-09-22
IL43571A0 (en) 1974-03-14
FI58912C (fi) 1981-05-11
CA1033727A (en) 1978-06-27
DE2355731A1 (de) 1974-05-22
ATA941073A (de) 1978-02-15
FR2291200B1 (es) 1979-01-05
CH593930A5 (es) 1977-12-30
IL43571A (en) 1977-08-31
ES456279A1 (es) 1978-11-01
FI58912B (fi) 1981-01-30
NO144385B (no) 1981-05-11
SE7701523L (sv) 1977-02-10
SU704456A3 (ru) 1979-12-15
NO143663C (no) 1981-03-25
JPS5714347B2 (es) 1982-03-24
BE807046A (fr) 1974-05-08
DK143499C (da) 1982-01-11
DE2355731B2 (de) 1980-04-30
ES444398A1 (es) 1977-12-01
GB1456838A (en) 1976-11-24
ZA738595B (en) 1974-09-25
SE412229B (sv) 1980-02-25
IL50310A (en) 1977-08-31
DK143499B (da) 1981-08-31
FR2205338B1 (es) 1978-07-13
AU6230273A (en) 1975-05-08
NO743616L (no) 1974-05-09
JPS49133357A (es) 1974-12-21
PH13320A (en) 1980-03-13
NO143663B (no) 1980-12-15
PH13261A (en) 1980-02-25
NL7315307A (es) 1974-05-10
AT345999B (de) 1978-10-10
NO144385C (no) 1981-08-19
SU667131A3 (ru) 1979-06-05
FR2291200A1 (fr) 1976-06-11
SE417957B (sv) 1981-04-27
IE40043B1 (en) 1979-02-28
SE7612262L (sv) 1976-11-03

Similar Documents

Publication Publication Date Title
ES420386A1 (es) Un procedimiento para preparar un pentanorprostaglandinas.
GB1515414A (en) 2 descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanorprostaglandins
DE69219885D1 (de) 7-chromanylester von phenolen und benzoesäuren mit retinoidähnlicher aktivität
ES420325A1 (es) Un procedimiento para preparar una prostaglandina.
GB1468012A (en) 2-amino-3-carboxy-thiophene derivatives
US4124621A (en) Cis-4,5-didehydro-12,13(e)-didehydro-13,14-dihydro-9-deoxy-PGD1 compounds
ES416865A1 (es) Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15.
GB1459564A (en) Alkylphenyl benzopyrans
ES368882A1 (es) Un procedimiento para preparar naftil alcanoles y sus deri-vados.
ES380859A1 (es) Un procedimiento para la preparacion de derivados de diben-zo-dioxocin.
GB1252329A (es)
GB1385150A (en) Sulphur-containing ring compounds and compositions thereof
GB1237054A (en) Derivatives of the 2-(lower alkyl)-3-(lower alkyl)-4-phenyl-3- or 4-cyclohexenecarboxylic acids
GB1496845A (en) (dl)-13-substituted sulphinyl-prostaglandin-like compounds and methods of making
FI832561A (fi) Nya (3,2,0)bicykloheptanonoximetrar med vaerdefulla terapeutiska egenskaper
GB1341780A (en) Cyclopenteneheptanoic acid derivatives
GB1377316A (en) Dialkylaminoalkyl esters of arylaliphatic acids and acid addition salts thereof
GB1318473A (en) Alpha-substituted-beta-benzo-b-thienyl-3-propionic acids and basic esters thereof
US4063026A (en) 4,5-Cis-didehydro-PGE1 analogs
GB1283451A (en) Ortho-substituted phenol ethers, their preparation and compositions containing them
ES372927A1 (es) Procedimiento de preparacion de nuevos derivados del acido ciclohexenil acetico.
GB1498377A (en) Alkyne derivatives and process for their preparation
US4321370A (en) 2,5-Inter-o-phenylene-3,4-dinor-6,9α-epoxy-6β-PGF1 compounds
US4003946A (en) 4,5-Cis-didehydro-PGF1 analogs
GB1480286A (en) 11-substituted-11-deoxy-pge analogues